Evidence map›Paper›PMID 29047094›Full record

ReviewAdvances in experimental medicine and biology2017

Endothelial Cell Reactive Oxygen Species and Ca

Karthik Suresh, Larissa A Shimoda

Open access · greenAbstract readReview
In one paragraph

Review in Advances in experimental medicine and biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Store-operated CaAmerican journal of physiology. Lung cellular and molecular physiology · 2025
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Reactive Oxygen Species and Endothelial CaInternational journal of molecular sciences · 2021
    Review
  11. Mitochondrial Monoamine Oxidase: Another Player in Pulmonary Hypertension?American journal of respiratory cell and molecular biology · 2021
    Article
  12. Cellular and Molecular Processes in Pulmonary Hypertension.Advances in experimental medicine and biology · 2021
    Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Karthik SureshDivision of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21224, USA. ksuresh2@jhmi.edu.
Larissa A ShimodaDivision of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21224, USA.
Johns Hopkins Medicine · US

Funding

Aquaporin 1 and pulmonary hypertensionR01HL126514 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI SHIMODA, LARISSA A. · 2015 to 2025
$4.5M
Na+/H+ exchange in pulmonary hypertensionR01HL073859 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI SHIMODA, LARISSA A. · 2003 to 2020
$4.2M
NHLBI NIH HHS R01 HL073859NHLBI NIH HHS R01 HL126514
6 · The paper itself

Abstract

Pulmonary hypertension (PH) refers to a disorder characterized by elevated pulmonary arterial pressure, leading to right ventricular overload and eventually right ventricular failure, which results in high morbidity and mortality. PH is associated with heterogeneous etiologies and distinct molecular mechanisms, including abnormal migration and proliferation of endothelial and smooth muscle cells. Although the exact details are not fully elucidated, reactive oxygen species (ROS) have been shown to play a key role in promoting abnormal function in pulmonary arterial smooth muscle and endothelial cells in PH. In endothelial cells, ROS can be generated from sources such as NADPH oxidase and mitochondria, which in turn can serve as signaling molecules in a wide variety of processes including posttranslational modification of proteins involved in Ca

Indexed as

Signal TransductionAnimalsCalciumCell ProliferationEndothelial CellsHumansHypertension, PulmonaryMitochondriaOxidation-ReductionReactive Oxygen SpeciesCalciumReactive Oxygen SpeciesCalcium homeostasisEndothelial cellHypoxiaMitochondriaNADPH oxidasePulmonary hypertensionReactive oxygen species

Identifiers

PMID29047094
PMCPMC7398047
OpenAlexW2766224958

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.